PSYCHEMEDICS CORPORATION - COMMON STOCK

Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders

18 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Reports Third Quarter 2024 Financial Results

12 Nov 2024 16:05:23 By Nasdaq GlobeNewswire

Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing

26 Sep 2024 09:00:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Launches New Ketamine Hair Testing Service

29 Aug 2024 09:00:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Reports Second Quarter 2024 Financial Results

13 Aug 2024 16:05:16 By Nasdaq GlobeNewswire

Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock

12 Aug 2024 16:12:58 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: PSYCHEMEDICS CORPORATION - COMMON STOCK

08 Aug 2024 15:52:54 By NetDania Notify

NetDania - New 12 months Low: PSYCHEMEDICS CORPORATION - COMMON STOCK

05 Aug 2024 13:40:55 By NetDania Notify

NetDania - New 12 months Low: PSYCHEMEDICS CORPORATION - COMMON STOCK

02 Aug 2024 13:42:15 By NetDania Notify

NetDania - New 12 months Low: PSYCHEMEDICS CORPORATION - COMMON STOCK

26 Jul 2024 15:35:48 By NetDania Notify

Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing

21 Jun 2024 10:00:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Reports First Quarter 2024 Financial Results

14 May 2024 16:55:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Reports 2023 Financial Results

28 Mar 2024 08:20:00 By Nasdaq GlobeNewswire

Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider

21 Mar 2024 09:00:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas

02 Jan 2024 11:27:42 By Nasdaq GlobeNewswire

Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance

27 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Reports Third Quarter 2023 Financial Results

09 Nov 2023 17:00:59 By Nasdaq GlobeNewswire

Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen

27 Oct 2023 11:00:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

21 Sep 2023 17:00:00 By Nasdaq GlobeNewswire

Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

18 Aug 2023 14:00:40 By Nasdaq GlobeNewswire